Using a Novel CDST to Guide the Assessment and Management of Low-/High-Risk Ulcerative Colitis

Program Overview

Clinical care pathways, based on extensive research, provide clear guidance on escalation of therapy for patients with mild ulcerative colitis (UC); however, in patients with moderate-to-severe UC, the selection of treatment is less clear. Recently a clinical decision support tool (CDST) has been developed using key clinical imaging and laboratory markers. This tool is specifically designed for patients with high burden of disease – namely those at high risk of colectomy. The tool assesses disease burden, uses risk and clinical/laboratory data to predict outcomes for certain drugs, and includes additional resources explaining how the prediction is calculated. Join Dr. Dubinsky in a virtual demonstration of the tool using patient case vignettes.

Credit Expired

Target Audience

This activity is intended for clinicians who manage patients with inflammatory bowel disease (IBD).

Educational Objectives

Upon completion of this activity, participants should be better able to:

Apply novel, predictive decision support tools to stratify patients with inflammatory bowel disease (IBD) based on complication risk and disease severity in order to inform appropriate treatment initiation and timing
Integrate biologics into the treatment regimen for IBD based on individual probability of response to specific biologics

Activity Faculty

Parambir Dulai, MD (Chair)

Assistant Professor
UC San Diego School of Medicine
San Diego, CA

Joshua Rubin, MD (Co-Chair)

Assistant Clinical Professor
UC San Diego School of Medicine
San Diego, CA

Marla C. Dubinsky, MD

Professor, Pediatrics and Medicine
Chief, Pediatric Gastroenterology and Nutrition
Co-Director, Susan and Leonard Feinstein IBD Clinical Center
Icahn School of Medicine
Mount Sinai Hospital
New York, NY

Featured RMEI CE Activities – Earn CE Credit(s)

Using a Novel CDST to Guide the Assessment and Management of Low-/High-Risk Ulcerative Colitis

Program Overview

Target Audience

Educational Objectives

Activity Faculty

Parambir Dulai, MD (Chair)

Joshua Rubin, MD (Co-Chair)

Marla C. Dubinsky, MD

Advances in Precision Medicine for Relapsed/Refractory Diffuse Large B-Cell Lymphoma Care: A Care Team Forum®

Refining Management of CMV After Transplant: Exploiting Recent Advances to Alleviate Patient Burden

Overcoming Obstacles to Optimal Multiple Sclerosis (MS) Care in Minority Patient Populations

Subscribe